NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation

被引:11
|
作者
Jia, Huan [1 ,4 ]
Nguyen, Yann [1 ,3 ]
Hochet, Baptiste [1 ]
Smail, Mustapha [1 ]
Mosnier, Isabelle [1 ]
Wu, Hao [4 ]
Sterkers, Olivier [1 ,3 ,4 ]
Kalamarides, Michel [2 ,3 ]
Bernardeschi, Daniele [1 ]
机构
[1] GH Pitie Salperriere, AP HP,Rare Dis Ctr Genet Deafiless Adult, Dept Otol Auditory Implants & Skull Base Surg, Ile de France Reference Ctr Cochlear Implant & Au, Paris, France
[2] GH Pitie Salperriere, AP HP, Dept Neurosurg, Rare Dis Ctr NF2, Paris, France
[3] Sorbonne Univ, Paris, France
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Cochlear implant; Intra-labyrinthine tumor; Intravestibular tumor; Neurofibromatosis type 2; Vestibular schwannoma; INTRALABYRINTHINE SCHWANNOMAS; HEARING PRESERVATION; DECOMPRESSION; DIAGNOSIS; REMOVAL; SERIES; MRI;
D O I
10.1097/MAO.0000000000002431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Intravestibular schwannomas (IVS) are uncommon tumors in Neurofibromatosis type 2 (NF2) and are mainly associated with multiple internal auditory meatus (IAM) and cerebellopontine angle (CPA) tumors. They usually induce profound hearing loss which can be rehabilitated by cochlear implantation (CI). The aim of this study was to analyze the long-term outcomes of CI during the unpredictable evolution of NF2 disease. Study Design: Retrospective case review. Setting: Tertiary referral center. Patients: Three adults with neurofibromatosis type 2 and intravestibular schwannomas, and who were cochlear implant recipients. Interventions: Periodic radiologic follow-up, tumor resection, and hearing rehabilitation. Main Outcome Measures: Audiological evolution, tumor evolution, surgical outcome, cochlear implant outcome. Results: Three NF2 patients (mean age at diagnosis, 26.3 +/- 3.2 yr) were identified with IVS in the period between 2000 and 2017. IVS were first observed by serial MRI and profound hearing loss occurred in this ear after 4 +/- 1.5 years of follow-up. IVS were removed via a translabyrinthine approach, and ipsilateral cochlear implantations were simultaneously performed. In two patients, large contralateral CPA tumors had previously been removed without hearing preservation, whereas in the third patient, a small, growing contralateral VS was excised via a retrosigmoid approach 6 months after IVS removal/cochlear implantation with serviceable hearing preservation. In all cases, CI provided good hearing outcomes. In two cases, hearing outcomes were even better for more than 5 years when ipsilateral intracanalicular vestibular schwannomas were removed in either the same or subsequent procedures. Conclusions: Rehabilitation of hearing with CI provides a favorable long-term outcome in patients with NF2-related IVS which could be altered by the occurrence of other intracanalicular and/or CPA NF2-related tumors.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 50 条
  • [1] ACTIVITY OF BEVACIZUMAB AGAINST NF2-RELATED VESTIBULAR SCHWANNOMAS
    Plotkin, Scott
    Halpin, Christopher
    Stemmer-Rachamimov, Anat
    Barker, Fred
    Sorensen, Gregory
    Jain, Rakesh
    Di Tomaso, Emmanuelle
    NEURO-ONCOLOGY, 2008, 10 (05) : 796 - 796
  • [2] Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes
    Grenier, Baptiste
    Mosnier, Isabelle
    Ferrary, Evelyne
    Nguyen, Yann
    Sterkers, Olivier
    Kalamarides, Michel
    Lahlou, Ghizlene
    Daoudi, Hannah
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (01) : 218 - 230
  • [3] Long-Term Outcomes of Cochlear Implantation in Usher Syndrome
    Fehrmann, Mirthe L. A.
    Lanting, Cris P.
    Haer-Wigman, Lonneke
    Yntema, Helger G.
    Mylanus, Emmanuel A. M.
    Huinck, Wendy J.
    Pennings, Ronald J. E.
    EAR AND HEARING, 2024, 45 (06): : 1542 - 1553
  • [4] Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications
    Flavia Sorrentino
    Giulia Tealdo
    Diego Cazzador
    Niccolò Favaretto
    Davide Brotto
    Silvia Montino
    Ezio Caserta
    Roberto Bovo
    Luca Denaro
    Valentina Baro
    Domenico D’Avella
    Alessandro Martini
    Antonio Mazzoni
    Gino Marioni
    Elisabetta Zanoletti
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 4709 - 4718
  • [5] Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications
    Sorrentino, Flavia
    Tealdo, Giulia
    Cazzador, Diego
    Favaretto, Niccolo
    Brotto, Davide
    Montino, Silvia
    Caserta, Ezio
    Bovo, Roberto
    Denaro, Luca
    Baro, Valentina
    D'Avella, Domenico
    Martini, Alessandro
    Mazzoni, Antonio
    Marioni, Gino
    Zanoletti, Elisabetta
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (10) : 4709 - 4718
  • [6] Changing Management of Intravestibular Schwannomas in the Era of Cochlear Implantation for Single-Sided Deafness
    Hershey, Emma
    Chionis, Lisa
    Kazemi, Ruby
    Valenzuela, Carla
    El-Kashlan, Hussam K.
    Basura, Gregory J.
    Stucken, Emily Z.
    OTOLOGY & NEUROTOLOGY, 2024, 45 (04) : e337 - e341
  • [7] TAM receptors as potential therapeutic targets in NF2-related schwannomas and meningiomas
    Dave, Foram
    Ammoun, Sylwia
    Hanemann, C. Oliver
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas
    Douwes, Jules P. J.
    van Eijk, Ronald
    Maas, Sybren L. N.
    Jansen, Jeroen C.
    Aten, Emmelien
    Hensen, Erik F.
    CANCERS, 2025, 17 (03)
  • [9] Pediatric cochlear implantation in Taiwan: Long-term communication outcomes
    Wang, Nan Mai
    Huang, Tsun Sheng
    Wu, Che-Ming
    Kirk, Karen Iler
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2007, 71 (11) : 1775 - 1782
  • [10] Long-Term Hearing Outcomes After Hybrid Cochlear Implantation
    Salmon, Mandy K. K.
    Quimby, Alexandra E. E.
    Bartellas, Michael
    Kaufman, Hannah S. S.
    Bigelow, Douglas C. C.
    Brant, Jason A. A.
    Ruckenstein, Michael J. J.
    OTOLOGY & NEUROTOLOGY, 2023, 44 (07) : 679 - 683